Old Mission Capital’s Benitec Biopharma BNTC Stock Holding History

Old Mission Capital’s Portfolio BNTC Stock Details BNTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-51	Closed	-$10K	–	221
2019 Q2	$10K	Buy	+51	New	+$20.7K	﹤0.01%	258

Other funds holding BNTC

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Old Mission Capital's BNTC Position: Q3 2019 in Review

Old Mission Capital sold out of Benitec Biopharma (BNTC) in Q3 2019, closing a stake of 51 shares — an estimated $10K sold.

Old Mission Capital first reported a position in BNTC in Q2 2019 and held it in 1 quarter. The position peaked at $10K in Q2 2019. 5 funds tracked by Wall St. Rank hold BNTC as of Q3 2019.

Old Mission Capital reported no remaining Benitec Biopharma position as of Q3 2019 after selling out during the quarter.
Old Mission Capital sold 51 Benitec Biopharma shares in Q3 2019, an estimated $10K.
Old Mission Capital first reported a position in Benitec Biopharma in Q2 2019 and held it in 1 quarter.
Old Mission Capital's Benitec Biopharma position peaked at $10K in Q2 2019.
5 funds tracked by Wall St. Rank held Benitec Biopharma as of Q3 2019.

Based on Old Mission Capital's 13F filing for Q3 2019, filed 14 Nov 2019.